Colon Cancer

Quality of life similar to those getting usual care

Clearly helpful in manufacturers' trials, but not so much in routine practice

Outdone by gastroenterologists in finding adenomatous polyps

But not a cure-all in states boosting eligibility

No increase in adverse events or toxicity versus surgery alone

Fewer actionable mutations, less likely to meet genomic criteria for immunotherapy

Moreover, a significant proportion do not qualify for genetic screening under current guidelines

Also in TTHealthWatch: antibiotic prophylaxis for sexually transmitted infections

News, features, and commentary about cancer-related issues

Physicians often ignore life expectancy in screening decisions, study finds

News, features, and commentary about cancer-related issues

News, features, and commentary about cancer-related issues

58% of seniors with limited life expectancy, no significant findings invited for another round

Trifluridine/tipiracil fails to improve survival in patients with KRAS G12-mutant tumors